2.12 0.00 (0.00%)
After hours: 5:54PM EDT
|Bid||2.00 x 800|
|Ask||2.27 x 1800|
|Day's Range||2.02 - 2.14|
|52 Week Range||2.02 - 11.98|
|Beta (3Y Monthly)||2.47|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 9, 2018|
|Forward Dividend & Yield||0.04 (1.89%)|
|1y Target Est||8.50|
ACETO Corporation (ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the first quarter of fiscal 2019 ended September 30, 2018 after the stock market close on Thursday, November 8, 2018. Callers who preregister will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator.
SAN DIEGO, CA / ACCESSWIRE / October 22, 2018 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares Aceto Corporation (NASDAQ: ACET). The plaintiff seeks ...
Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of Aceto Corporation (ACET) have filed a shareholder action against the company's officers and directors for breaches of their fiduciary duties between August 25, 2017 and April 18, 2018. Aceto develops, markets, sells, and distributes finished dosage form generic pharmaceuticals and nutraceutical products, among other products. According to the complaint, Aceto assured investors that the company's internal control over financial reporting was effective.
NEW YORK, Oct. 08, 2018 -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Aceto Corporation (NASDAQ: ACET). On.
This all-new Penny Stocks to Watch for October brings a broad mix of companies involved in industries as diverse as mining, financial services, industrial products and online gaming. A penny stock is generally defined as a stock that has a low share price and small market capitalization.
NEW YORK , Sept. 28, 2018 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of Aceto ...
On a per-share basis, the Port Washington, New York-based company said it had a loss of 98 cents. Losses, adjusted for amortization costs and pretax expenses, came to 48 cents per share. The chemical company ...
Performance Chemicals and Pharmaceutical Ingredients Continue Strong Performance. Repaid $43.2 Million of Debt During Fiscal Year 2018. PORT WASHINGTON, N.Y., Sept. 28, 2018-- ACETO Corporation, an international ...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Sept. 25) Abbott Laboratories (NYSE: ABT ) Amarin Corporation ...
NEW YORK , Sept. 25, 2018 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: S&P MidCap 400 constituent Rollins Inc. (NYSE: ROL) ...
SAN DIEGO, Sept. 17, 2018-- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Aceto Corporation shares. Investors who purchased shares of Aceto Corporation ...
The Amendment provides for a waiver of any event of default on the total net leverage ratio, senior secured net leverage ratio and debt service coverage ratio financial covenants for the fiscal quarters ended or ending June 30, 2018, September 30, 2018, December 31, 2018, March 31, 2019 and June 30, 2019. In addition, the Amendment allows for greater capital expenditures and investments, places limitations on the payment of quarterly dividends, increases the interest rate payable on all loans under the A&R Credit Agreement and requires the company to maintain minimum liquidity levels, among other amendments. The Amendment will be filed on Form 8-K with the Securities and Exchange Commission (“SEC”) today. Separately, the Company also announced that it will file a Notification of Late Filing on Form 12b-25 with the SEC for an automatic fifteen-day extension to file its Annual Report on Form 10-K for the fiscal year ended June 30, 2018. Shortly before the anticipated timely filing of the Annual Report, a decision was made that additional analysis would be required to determine if it would be appropriate to record an additional valuation allowance for the fiscal year ended June 30, 2018 with respect to net deferred tax assets.
ACETO Corporation (ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the fourth quarter and full year of fiscal 2018 ended June 30, 2018 after the stock market close on Wednesday, September 12, 2018. Management will host a conference call to discuss the operating and financial results at 9:00 a.m. ET on Thursday, September 13, 2018. Callers who preregister will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator.
NEW YORK, Aug. 03, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Aceto ...
LONDON, UK / ACCESSWIRE / July 9, 2018 / If you want a free Stock Review on DWDP sign up now at www.wallstequities.com/registration. Selected for assessment this morning are four major industry players, particularly: Aceto Corp. (NASDAQ: ACET), Ashland Global Holdings Inc. (NYSE: ASH), DowDuPont Inc. (NYSE: DWDP), and Huntsman Corp. (NYSE: HUN). Port Washington, New York headquartered Aceto Corp.'s shares recorded a trading volume of 279,152 shares last Friday.
ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until June 25, 2018 to file lead plaintiff applications in a securities class action lawsuit against Aceto Corporation .
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until June 25, 2018 to file lead plaintiff applications in a securities class action lawsuit against Aceto Corporation (ACET). Investor losses must relate to purchases of the Company’s shares between August 25, 2017 and April 18, 2018. This action is pending in the United States District Court for the Eastern District of New York.
RADNOR, PA / ACCESSWIRE / June 21, 2018 / Kessler Topaz Meltzer & Check, LLP reminds Aceto Corporation (ACET) (''Aceto'') investors that a class action lawsuit has been filed on behalf of purchasers of Aceto common stock between August 25, 2017 and April 18, 2018, inclusive (the ''Class Period''). FINAL REMINDER: Investors who purchased Aceto securities during the Class Period may, no later than June 25, 2018, seek to be appointed as a lead plaintiff representative of the class. According to the complaint, Aceto is an international company engaged in the development, marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products.